Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 gag

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2643-2649

  Porter, Donna C ^a   Melsen, Lawrence R ^b   Compans, Richard W ^b   Morrow, Casey D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN IMMUNODEFICIENCY VIRUS 1; MYRISTYLATION; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN PROCESSING; REPLICON; STRUCTURAL GENE; VIRUS PARTICLE;

EID: 0029922881     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2643-2649.1996     Document Type: Article

References (72)

1. Alexander, L., H. H. Lu, and E. Wimmer. 1994. Poliovirus containing picornavirus type 1 and or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign gene. Proc Natl Acad. Sci USA 91:1406-1410.
2. smm PBj14. Submitted for publication
3. Andino, R., E. Rieckhof, P. L. Achacoso, and D. Baltimore. 1993 Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J. 12:3587-3598.
4. Andino, R., D. Silvera, S. D. Suggett, P. L. Achacoso, C. J. Miller, D. Baltimore, and M. B. Feinberg. 1994. Engineering poliovirus as vaccine vector for the expression of diverse antigens. Science 265:1448-1451.
5. Ansardi, D. C., Z. Moldoveanu, D. C. Porter, D. E. Walker, R. M. Conry, A. F. LoBuglio, S. McPherson, and C. D. Morrow. 1994. Characterization of poliovirus replicons encoding carcinoembryonic antigens Cancer Res. 54:6359-6363
6. Ansardi, D. C., D. C. Porter, and C. D. Morrow. 1991. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J. Virol. 65:2088-2092.
7. Ansardi, D. C., D. C. Porter, and C. D. Morrow. 1992. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles J. Virol 66:4556-4563
8. Ansardi, D. C., D. C. Porter, and C. D. Morrow. 1993 Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides P1 capsid precursor in trans. 3. Virol. 67:3684-3690
9. Bienz, K., D. Egger, Y. Rasser, and W. Bossart. 1980. Kinetics and location of poliovirus macromolecular synthesis in correlation to virus induced cytopathology. Virology 100:390-399.
10. Bienz, K., D. Egger, Y. Rasser, and W. Bossart. 1983. Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures. Virology 31:39-48
11. Bryant, M., and L. Ratner. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl Acad Sci USA 87:523-527
12. Choi, H. K., L. Tong, W. Minor, P. Dumas, U. Boege, M. G. Rossman, and G. Wengler. 1991 Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature (London) 354:37-43
13. Choi, W. S., R. Pal-Ghosh, and C. D. Morrow. 1991. Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol. and env proteins from chimeric HIV-1-poliovirus minireplicons. J. Virol 65:2875-2883
14. Chow, M., J. F. E. Newman, D. J. Filman, J. M. Hogle, D. J. Rowlands, and F. Brown. 1987. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature (London) 327:482-486.
15. Dales, S., H. J. Eggers, I. Tamm, and G. E. Palade. 1965 Electron microscopic study of the formation of poliovirus. Virology 26:379-389.
16. Evans, D. J., J. McKeating, K. L. Meredith, K. L. Burke, K. Katrack, A. John, P. D. Ferguson, P. D. Minor, R. A. Weiss, and J. W. Almond. 1989 An engineered poliovirus chimera elicits broadly reactive HIV-1 neutralizing antibodies. Nature (London) 339:385-388.
17. gg virus-like particles from recombinant baculovirus-infected insect cells Cell 59:103-112.
18. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989 Role of psid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785
19. Haffar, O., J. Garrigues, B. Travis, P. Moran, J. Zarling, and S.-L. Hu. 1990. Human immunodeficiency virus-like, nonreplicating, gag-em particles assemble in a recombinant vaccinia virus expression system. J. Virol 64:2653-2659.
20. Hagino-Yamagishi, K., and A. Nomoto. 1989. In vitro construction of poliovirus defective interfering particles. J. Virol. 63:5386-5392.
21. Harris, K. S., C. U. T. Hellen, and E. Wimmer. 1990. Proteolytic processing in the replication of picornaviruses Semin. Virol. 1:323-333.
22. Hellen, C. U. T., C. K. Lee, and E. Wimmer. 1992. Determinants of substrate recognition by poliovirus 2A proteinase. J. Virol. 66:3330-3338.
23. Hu, S.-L., B. M. Travis, J. Garrigues, J. M. Zarling, P. Sridhar, T. Dykers, J. W. Eichberg, and C. Alpers. 1990. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus. Virology 179:321-329.
24. Hu, W.-S., and H. M. Temin. 1990. Retroviral recombination and reverse transcription. Science 250:1227-1233
25. Jenkins, O., J. Cason, K. L. Burke, D. Lunney, A. Gillen, D. Patel, D. J. McCance, and J. W. Almond. 1990. An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16. J. Virol. 64:1201-1206.
26. Jore, J., B. DeGeus, R. J. Jackson, P. H. Pouwels, and B. E. Enger-Valk. 1988. Poliovirus protein 3CD is the active protease for processing of the precursor protein P1 in vitro. J. Gen. Virol. 69:1627-1636.
27. Kaplan, G., and V. R. Racaniello. 1988. Construction and characterization of poliovirus subgenomic replicons. J. Virol. 62:1687-1696.
28. Karacostas, V., K. Nagashima, M. Gonda, and B. Moss. 1989. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86:8964-8965.
29. Katoh, I., Y. Yoshinaka, A. Rei, M. Shibuya, T. Odaka, and S. Oroszlan. 1985. Murine leukemia virus maturation: protease region required for conversion from 'immature' to 'mature' core form and for virus infectivity. Virology 145:280-292.
30. Kitamura, N., B. L. Semler, P. G. Rothberg, G. R. Larsen, C. J. Adler, A. J. Dorner, E. A. Emini, R. Hanecak, J. J. Lee, S. van der Werf, C. W. Anderson, and E. Wimmer. 1981. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (London) 291:547-553.
31. Kitson, J. D. A., K. L. Burke, L. A. Pullen, G. J. Belsham, and J. W. Almond. 1991. Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. J Virol. 65:3068-3075.
32. Koch, F., and G. Koch. 1985. The molecular biology of poliovirus. Springer-Verlag, Vienna.
33. Kuhn, R. J., and E. Wimmer. 1987. The replication of picornaviruses, p. 17-51. In D. J. Rowlands, M. A. Maho, and B. W. J. Mahy (ed.), Molecular biology of positive-strand RNA viruses. Academic Press, Ltd., London.
34. Luo, L., Y. Li, P. M. Cannon, S. Kim, and C. Y. Kang. 1992. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Proc. Natl. Acad Sci. USA 89:10527-10531.
35. Mattion, N. M., P. A. Reilly, E. Camposano, S.-L. Wu, S. J. DiMichele, S. T. Ishizaka, S. E. Fantini, J. C. Crowley, and C. Weeks-Levy. 1995. Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus Type 2 glycoprotein D. J. Virol. 69:5132-5137.
36. Mattion, N. M., P. A. Reilly, S. J. DiMichele, J. C. Crowley, and C. Weeks-Levy. 1994. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses. J. Virol. 68:3925-3933.
37. Melnick, J. 1978. Advantages and disadvantages of killed and live poliomyelitis vaccines. Bull. W. H. O 56:21-38.
38. Merenger, K., M. Facke, R. Welker, V. Brinkman, H. R. Gelderblom, and H.-G. Kräusslich. 1992. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology 186:25-39.
39. Moldoveanu, Z., D. C. Porter, A. Lu, S. McPherson, and C. D. Morrow. 1995. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Vaccine 13:1013-1022
40. Morrow, C. D., D. C. Porter, D. C. Ausardi, Z. Moldoveanu, and P. N. Fultz. 1994. New approaches for mucosal vaccines for AIDS: encapsidation and serial passage of poliovirus replicons that express HIV-1 proteins on infection. AIDS Res. Hum. Retroviruses 10:S61-S66.
41. Nicklin, M. J. H., H. G. Kräusslich, H. Toyoda, J. J. Dunn, and E. Wimmer. 1987. Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc. Natl. Acad Sci. USA 84:4002-4006.
42. Ogra, P. L. 1984 Mucosal immune response to poliovirus vaccines in childhood. Rev. Infect. Dis. 6:S361-S368.
43. Ogra, P. L., E. E. Leibovitz, and G. Zhao-Ri. 1989. Oral immunization and secretory immunity to viruses. Curr. Top Microbiol. Immunol. 146:73-81.
44. Pal, R., M. S. Reitz, E. Tschachler, R. C. Gallo, M. G. Sarngadharan, and F. D. M. Veronese. 1990. Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly. AIDS Res. Hum. Retroviruses 6:721-730.
45. Palmenberg, A. C. 1990. Proteolytic processing of picornaviral polyprotein. Annu Rev. Microbiol. 44:603-623.
46. Park, J., and C. D. Morrow. 1991 Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J. Virol. 65:5111-5117.
47. gag and is incorporated into viruslike particles. J. Virol. 66:6304-6313.
48. Paul, A. V., A. Schultz, S. E. Pincus, S. Oroszlan, and E. Wimmer. 1987. Capsid protein VP4 of poliovirus is N-myristoylated. Proc. Natl. Acad. Sci. USA 84:7827-7831.
49. Percy, N., W. S. Barclay, M. Sullivan, and J. W. Almond. 1992. A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA. J. Virol. 66:5040-5046.
50. Porter, D. C., D. C. Ansardi, W. S. Choi, and C. D. Morrow. 1993. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. J. Virol. 67:3712-3719.
51. Porter, D. C., D. C. Ansardi, and C. D. Morrow. 1995. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans. J. Virol. 69:1548-1555.
52. Pol. Virus Res. 29:241-254.
53. Racaniello, V. R., and D. Baltimore. 1981. Molecular cloning of poliovirus DNA and determination of the complete nucleotide sequence of the viral genome. Proc. Natl. Acad. Sci USA 78:4887-4891.
54. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. K. Doran, J. A. Ratalski, E. A. Whitehorn, K. Baumeister, L. Ivanoff, J. S. R. Petteway, M. L. Pearson, J. A. Lautenberge, T. S. Papas, J. Ghrayeb, N. T. Chang, R. C. Gallo, and F. Wong-Staal. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (London) 313:277-284.
55. Royer, M., S.-S. Hong, B. Gay, M. Cerutti, and P. Boulanger. 1992 Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells. J. Virol 66:3230-3235.
56. Rueckert, R. R. 1990. Picornaviridae and their replication, p. 507-547 In B. M. Fields et al (ed.), Virology. Raven Press, New York.
57. Sabin, A. B., and L. R. Boulger. 1973. History of Sabin attenuated poliovirus oral live vaccine strains. J Biol Stand 1:115-118.
58. Shioda, T., and H. Shibuta. 1990. Production of human immunodeficiency virus (HlV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology 175:139-145
59. Simons, J., M. Kutubuddin, and M. Chow. 1993. Characterization of polio-virus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J. Virol. 67:1262-1268.
60. gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles J. Virol. 64:2743-2750.
61. Smith, D. J., L. Gahnberg, M. A. Taubman, and J. L. Ebersole. 1986. Salivary antibody responses to oral and parenteral vaccines in children J. Clin. Immunol. 6:43-49.
62. gag expressed in bacteria. Virology 150:283-290.
63. Towler, D. A., S. P. Adams, S. R. Eubanks, D. S. Towery, E. Jackson-Machelky, L. Glaser, and J. I. Gordon. 1987. Purification and characterization of yeast myristoyl CoA:protein N-myristoyltransferase. Proc. Natl. Acad Sci USA 84:2708-2712.
64. Toyoda, H., J. H. Nicklin, M. G. Murray, C. W. Anderson, J. J. Dunn, F. W. Studies, and E. Wimmer. 1986. A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45:761-770.
65. Trono, D., M. B. Feinberg, and D. Baltimore. 1989. HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59:113-120.
66. Vzorov, A. N., M. I. Bukrinsky, V. B. Grigoriev, Y. Y. Tentsov, and A. G. Bukrinskaya. 1991. Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells. AIDS Res. Hum. Retroviruses 7:29-36.
67. gag retrovirus-like particles. Virology 200:162-175.
68. Wilcox, C., J. S. Hu, and E. N. Olson. 1987. Acylation of proteins with myristic acid occurs, cotranslationally. Science 238:1275-1278.
69. Wills, J. W., and R. C. Craven. 1991 Form, function, and use of retroviral gag proteins. AIDS 5:639-654
70. Wimmer, E., R. J. Kuhn, S. Pincus, C.-F. Yang, H. Toyoda, M. J. H. Nicklin, and N. Takeda. 1987. Molecular events leading to picornavirus genome replication. J. Cell Sci. Suppl. 7:251-276
71. Ypma-Wong, M. F., P. G. Dewalt, V. H. Johnson, J. G. Lamb, and B. L. Semler. 1988. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 166:265-270.
72. Ypma-Wong, M. F., and B. L. Semler. 1987. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins. J. Virol. 61:3181-3189.